Your logo

Prostate News Archive


  • Early detection is key in surviving prostate cancer (Point Pleasant Register)

    POINT PLEASANT - There will be approximately 235,000 new cases of it diagnosed in the United States this year. And while one man in every six will get prostate cancer during his lifetime, only one in 34 will die of the disease, with the survival rate increasing each year.

  • Prostate cancer drugs may raise health risk, study says (Contra Costa Times)

    Drugs commonly used to treat prostate cancer may increase the risk of heart disease and diabetes, indicating the treatments should be used more judiciously, researchers reported this week.

  • Prostate cancer support group: Early detection key (Marshfield News Herald)

    Learning that they have prostate cancer can be a scary proposition for men.

  • Prostate cancer drug raises heart, diabetes risk (Reuters via Yahoo! News)

    Hormone therapy used to treat prostate cancer that has already spread may save patients from cancer but raise the risk of diabetes and heart disease, U.S. researchers reported on Tuesday.

  • Positive clinical results for Active Biotech's prostate cancer project TASQ (SYS-CON Media)

    Active Biotech (ACTI.ST). An interim analysis of the ongoing TASQ Phase I study shows a treatment effect for all evaluated prostate cancer patients. Phase II/III studies are planned to start in year 2007.

  • New prostate probe does it all in 1 shot (St. Louis Post-Dispatch)

    A local company has developed a scanning system that allows physicians to more accurately detect and treat prostate cancer, a leading cause of death among men.

  • Prostate Cancer May Up Risk for Diseases (RedNova)

    Men with prostate cancer have high five-year survival rates, but they also have higher rates of non-cancer mortality, finds a U.S. study. Study author Dr.

  • Prostate cancer treatment may raise health risk --- HealthandAge (HealthandAge)

    Hormone treatment for prostate cancer increases men's risk of diabetes and heart disease. Blocking testosterone production by the use of GnRH agonists is a common treatment for prostate cancer.

  • Back to Prostate News Archive